Citations (25)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Abd El-Fattah B. M. El-Beltagy, Amira M.B. Saleh, Amany Attaallah & Reham A. Gahnem. (2021) Therapeutic role of Azadirachta indica leaves ethanolic extract against diabetic nephropathy in rats neonatally induced by streptozotocin. Ultrastructural Pathology 45:6, pages 391-406.
Read now
Read now
Articles from other publishers (24)
Esraa K. Abd-alhameed, Amany A. Azouz, Amira M. Abo-Youssef & Fares E.M. Ali. (2024) The enteroprotective effect of nifuroxazide against methotrexate-induced intestinal injury involves co-activation of PPAR-γ, SIRT1, Nrf2, and suppression of NF-κB and JAK1/STAT3 signals. International Immunopharmacology 127, pages 111298.
Crossref
Crossref
R.M. Salama & M.A. Omar. (2023) Anti-aging effect of nifuroxazide on skin changes of aged male rat models via modulating immunoreactivity of IL-6/NF-κB/Caspase-3. Morphologie 107:359, pages 100605.
Crossref
Crossref
Emad H. M. Hassanein, Mustafa Ahmed Abdel-Reheim, Hanan S. Althagafy, Mohamed S. Hemeda, Rania A. Gad & Asmaa Ramadan Abdel-Sattar. (2023) Nifuroxazide attenuates indomethacin-induced renal injury by upregulating Nrf2/HO-1 and cytoglobin and suppressing NADPH-oxidase, NF-κB, and JAK-1/STAT3 signals. Naunyn-Schmiedeberg's Archives of Pharmacology.
Crossref
Crossref
Yingjun Liu, Wenkuan Wang, Jintao Zhang, Shuo Gao, Tingting Xu & Yonghui Yin. (2023) JAK/STAT signaling in diabetic kidney disease. Frontiers in Cell and Developmental Biology 11.
Crossref
Crossref
Hanan S. Althagafy, Mostafa K. Abd El-Aziz, Islam M. Ibrahim, Esraa K. Abd-alhameed & Emad H.M. Hassanein. (2023) Pharmacological updates of nifuroxazide: Promising preclinical effects and the underlying molecular mechanisms. European Journal of Pharmacology 951, pages 175776.
Crossref
Crossref
Hala M.F. Mohammad, Sahar Galal Gouda, Mohamed Ahmed Eladl, Amany Y. Elkazaz, Khaled S. Elbayoumi, Noha E. Farag, Amr Elshormilisy, Buthainah B. Al-Ammash, Ann Hegazy, Sozan M. Abdelkhalig, Abir S. Mohamed, Mohamed El-Dosoky & Sawsan A. Zaitone. (2023) Metformin suppresses LRG1 and TGFβ1/ALK1-induced angiogenesis and protects against ultrastructural changes in rat diabetic nephropathy. Biomedicine & Pharmacotherapy 158, pages 114128.
Crossref
Crossref
Tommaso Ceruti, Quintino Giorgio D’Alessandris, Roberta Frapolli, Jay Gopalakrishnan, Mariachiara Buccarelli, Marina Meroni, Liverana Lauretti, Lucia Ricci-Vitiani, Roberto Pallini & Massimo Zucchetti. (2022) Development and Validation of a HPLC–MS/MS Method to Measure Nifuroxazide and Its Application in Healthy and Glioblastoma-Bearing Mice. Pharmaceutics 14:10, pages 2071.
Crossref
Crossref
Lini Song, Xi Cao, Wenyi Ji, Lili Zhao, Weili Yang, Ming Lu & Jinkui Yang. (2022) Inhibition of STAT3 enhances UCP1 expression and mitochondrial function in brown adipocytes. European Journal of Pharmacology 926, pages 175040.
Crossref
Crossref
Mohamed El-Sherbiny, Mohamed El-Shafey, Eman Said, Gehan Ahmed Shaker, Mohamed El-Dosoky, Hasnaa Ali Ebrahim, Sally Yussef Abed, Khalid M. Ibraheem, Ahmed Mohsen Faheem, Muntazar AlMutawa, Bayader Alatawi & Nehal M. Elsherbiny. (2022) Dapagliflozin, Liraglutide, and Their Combination Attenuate Diabetes Mellitus-Associated Hepato-Renal Injury—Insight into Oxidative Injury/Inflammation/Apoptosis Modulation. Life 12:5, pages 764.
Crossref
Crossref
Cailing Gan, Qianyu Zhang, Hongyao Liu, Guan Wang, Liqun Wang, Yali Li, Zui Tan, Wenya Yin, Yuqin Yao, Yongmei Xie, Liang Ouyang, Luoting Yu & Tinghong Ye. (2022) Nifuroxazide ameliorates pulmonary fibrosis by blocking myofibroblast genesis: a drug repurposing study. Respiratory Research 23:1.
Crossref
Crossref
Mohamed El-Sherbiny, Rehab M. El-Sayed, Mohamed A. Helal, Afaf T. Ibrahiem, Hoda S. Elmahdi, Mohamed Ahmed Eladl, Shymaa E. Bilay, Asma M. Alshahrani, Mona K. Tawfik, Ziad E. Hamed, Amany O. Mohamed & Sawsan A. Zaitone. (2021) Nifuroxazide Mitigates Angiogenesis in Ehlrich’s Solid Carcinoma: Molecular Docking, Bioinformatic and Experimental Studies on Inhibition of Il-6/Jak2/Stat3 Signaling. Molecules 26:22, pages 6858.
Crossref
Crossref
Fares E.M. Ali, Mohamed M. Elfiky, Walaa A. Fadda, Howaida S. Ali, Amany Refaat Mahmoud, Zuhair M. Mohammedsaleh & Tarek Hamdy Abd-Elhamid. (2021) Regulation of IL-6/STAT-3/Wnt axis by nifuroxazide dampens colon ulcer in acetic acid-induced ulcerative colitis model: Novel mechanistic insight. Life Sciences 276, pages 119433.
Crossref
Crossref
Nabila M.E. Hassan, Eman Said & George S.G. Shehatou. (2021) Nifuroxazide suppresses UUO-induced renal fibrosis in rats via inhibiting STAT-3/NF-κB signaling, oxidative stress and inflammation. Life Sciences 272, pages 119241.
Crossref
Crossref
Suliman Y. Alomar, Bassant M. Barakat, Mohamed Eldosoky, Hoda Atef, Abdelaty Shawky Mohamed, Reda Elhawary, Mohamed El-Shafey, Amal M. Youssef, Amany Y. Elkazaz, Attia M. Gabr, Abdelhakeem A. Elaskary, Mohamed A.K. Salih, Sultan Othman Alolayan & Sawsan A. Zaitone. (2021) Protective effect of metformin on rat diabetic retinopathy involves suppression of toll-like receptor 4/nuclear factor-k B expression and glutamate excitotoxicity. International Immunopharmacology 90, pages 107193.
Crossref
Crossref
Mahrokh Samadi, Shiva Gholizadeh-Ghaleh Aziz & Roya Naderi. (2020) The effect of tropisetron on oxidative stress, SIRT1, FOXO3a, and claudin-1 in the renal tissue of STZ-induced diabetic rats. Cell Stress and Chaperones 26:1, pages 217-227.
Crossref
Crossref
Sharifa Alzahrani, Sawsan A. Zaitone, Eman Said, Mohamed El-Sherbiny, Sadeem Ajwah, Sumayyah Yasser Alsharif & Nehal M. Elsherbiny. (2020) Protective effect of isoliquiritigenin on experimental diabetic nephropathy in rats: Impact on Sirt-1/NFκB balance and NLRP3 expression. International Immunopharmacology 87, pages 106813.
Crossref
Crossref
Yousra M. El-Far, Nehal M. Elsherbiny, Mohamed El-Shafey & Eman Said. (2020) The interplay of the inhibitory effect of nifuroxazide on NF-κB/STAT3 signaling attenuates acetic acid-induced ulcerative colitis in rats. Environmental Toxicology and Pharmacology 79, pages 103433.
Crossref
Crossref
Ahmed E. Khodir, Yara A. Samra & Eman Said. (2020) A novel role of nifuroxazide in attenuation of sepsis-associated acute lung and myocardial injuries; role of TLR4/NLPR3/IL-1β signaling interruption. Life Sciences 256, pages 117907.
Crossref
Crossref
Ahmed E. Khodir & Eman Said. (2020) Nifuroxazide attenuates experimentally-induced hepatic encephalopathy and the associated hyperammonemia and cJNK/caspase-8/TRAIL activation in rats. Life Sciences 252, pages 117610.
Crossref
Crossref
Kavya Jash, Piyush Gondaliya, Prathibha Kirave, Bhagyashri Kulkarni, Aditya Sunkaria & Kiran Kalia. (2020) Cognitive dysfunction: A growing link between diabetes and Alzheimer's disease. Drug Development Research 81:2, pages 144-164.
Crossref
Crossref
Jing-Yi Liu, Yi-Chen Zhang, Li-Ni Song, Lin Zhang, Fang-Yuan Yang, Xiao-Rong Zhu, Zhi-Qiang Cheng, Xi Cao & Jin-Kui Yang. (2019) Nifuroxazide ameliorates lipid and glucose metabolism in palmitate-induced HepG2 cells. RSC Advances 9:67, pages 39394-39404.
Crossref
Crossref
Nehal M. Elsherbiny, Eman Ahmed, Ghada Abdel Kader, Yousra Abdel-mottaleb, Mohamed H. ElSayed, Amal M. Youssef & Sawsan A. Zaitone. (2019) Inhibitory effect of valproate sodium on pain behavior in diabetic mice involves suppression of spinal histone deacetylase 1 and inflammatory mediators. International Immunopharmacology 70, pages 16-27.
Crossref
Crossref
Sheng-lei Yan, Zhi-hong Wang, Mei-chin Mong, Ya-chen Yang & Mei-chin Yin. (2019) Combination of carnosine and asiatic acid provided greater anti-inflammatory protection for HUVE cells and diabetic mice than individual treatments of carnosine or asiatic acid alone. Food and Chemical Toxicology 126, pages 192-198.
Crossref
Crossref
Yu-Si Cheng, Jie Chao, Chen Chen, Lin-Li Lv, Yu-Chen Han & Bi-Cheng Liu. (2019) The PKCβ-p66shc-NADPH oxidase pathway plays a crucial role in diabetic nephropathy. Journal of Pharmacy and Pharmacology 71:3, pages 338-347.
Crossref
Crossref